Diabetic Microvascular Complications Perspective

 
 
  • Jan 27 2023 This Week in Cardiology   Exercise for AF, drugs have more than one effect, AI bots and the future of medicine, and the good and bad news about prognosis in HF are the topics John Mandrola, MD, discusses in this week's podcast.
  • IDF 2022 Read clinically focused news coverage of key developments from IDF 2022
  • We Have an Amputation Epidemic Changing the paradigm from "amputate first and ask questions later" will benefit patients with diabetes and is a key initiative of the American Diabetes Association.
  • Does Spinal Cord Stimulation Improve Diabetic Neuropathy?   Rod S. Taylor, MSc, PhD, discusses a recent trial using spinal cord stimulation for painful diabetic neuropathy and its potential for long-term use in improving pain and quality of life.
  • EASD 2022 Read clinically focused news coverage of key developments from EASD 2022
  • Putting the Patient First: Top Insights From ADA 2022   From new guidelines for managing glucose to possible remission of type 2 diabetes, Dr Akshay Jain reviews what he feels are the most important studies from the ADA Scientific Sessions.
  • ASRS 2022 Read clinically focused news coverage of key developments from ASRS 2022
  • Glycemic Control in Type 2 Diabetes From ADA 2022   Dr Ildiko Lingvay reports on the ADA's changing standards of care for patients with diabetes and key studies in glycemic control, including results from the SURMOUNT-1 study presented at ADA 2022.
  • Type 2 Diabetes With Chronic Kidney Disease   Experts in endocrinology, preventive cardiology, and nephrology collaborate on a comprehensive treatment plan for a patient with type 2 diabetes who is at high risk for a cardiovascular event.
  • ENDO 2022 Read clinically focused news coverage of key developments from ENDO 2022
  • ADA 2022 Read clinically focused news coverage of key developments from ADA 2022
  • 'Turning Red' Provides Positive Depiction of Diabetes Pixar's newest animated film features two background characters with visible diabetes technology, a leap forward in portrayals of diabetes in mainstream media.
  • Beyond Glucose: Reducing CVD in Patients With Diabetes: Modifying all Factors   UC cardiologists discuss the need for a combination of lifestyle modification and risk-reduction therapy to optimally manage CVD risk in patients with diabetes.
  • Did I Miss a Better Peripheral Neuropathy Treatment? After Medscape readers offered their opinions on his management of a patient with diabetic peripheral neuropathy, Dr Charles Vega took a closer look at two unique alternatives.
  • Diabetes & Kidney Disease: A Heart in Jeopardy: Helping a Hero   An Air Force veteran with CKD shares his experience managing multiple chronic conditions and participating in research trials.
  • ARVO 2022 Read clinically focused news coverage of key developments from ARVO 2022
  • Beyond Glucose: Reducing CVD in Patients With Diabetes: Integrative Approach   Cardiologists discuss the multiple evidence-based treatment modalities, such as acupuncture, included in the UC Irvine preventive cardiology program.
  • Long-Term Anti-VEGF Delivery System Draws Closer to Primetime The Port Delivery System is a refillable intravitreal implant designed to deliver a continuous supply of ranibizumab into the vitreous. Is it as good as intravitreal ranibizumab injections?
  • Episode 3: How to Reduce Renal Risk in Type 2 Diabetes   Want to prevent kidney disease progression in patients with type 2 diabetes? Join host Dr Silvio Inzucchi and nephrologist Dr David Cherney as they unpack the how and why behind current recommendations.
  • Machine Learning in Rheumatology: Beyond Clinical Instincts Recent examples of machine learning in rheumatology provide a promising framework for showing how its power can be harnessed in clinical care, says Karmela Kim Chan, MD.